Clinical News

Check out this recap of articles published on our sister sites during the past week.

In posters presented at the American College of Clinical Pharmacy 2024 Annual Meeting, researchers explored the implementation of collaborative care programs within various health systems.

Check out this recap of articles published on our sister sites during the past week.

Check out this recap of articles published on our sister sites during the past week.

Check out this recap of articles published on our sister sites during the past week.

Check out this recap of articles published on our sister sites during the past week.

In its first move since the July interim report detailing pharmacy benefit manager practices, the FTC is now suing CVS Caremark, Express Scripts, and Optum Rx.

Check out this recap of articles published on our sister sites during the past week.

Check out this recap of articles published on our sister sites during the past week.

Check out this recap of articles published on our sister sites during the past week.

Check out this recap of articles published on our sister sites during the past week.

Check out this recap of articles published on our sister sites during the past week.

Researchers aimed to discover whether pharmacist-led delivery of oral anticoagulation therapy can lead to an increase in stroke risk reduction for patients with actionable atrial fibrillation.

Check out this recap of articles published on our sister sites during the past week.

Check out this recap of articles published on our sister sites during the past week.

Researchers compared health care and prescription medication affordability during the COVID-19 pandemic to pre-pandemic numbers.

Check out this recap of articles published on our sister sites during the past week.

Check out this recap of articles published on our sister sites during the past week.

Check out this recap of articles published on our sister sites during the past week.

In a session presented at the 2024 Heart in Diabetes Conference, Matthew Weir, MD, discussed the potential benefits of GLP-1s and SGLT2 inhibitors for improved chronic kidney disease and cardiovascular outcomes.

Check out this recap of articles published on our sister sites during the past week.

Check out this recap of articles published on our sister sites during the past week.

Researchers analyzed groups of men given financial incentives to motivate weight-loss behaviors compared with a non-incentivized control group.

Altuviiio was first granted approval by the FDA in February 2023.

A review found that many guidelines that recommended pharmacogenetic testing were inconsistent between clinical associations.

Recent safety data also allowed four adverse events to be removed from the label.

How does AI help reduce the burden on specialist dermatology services and help simplify the screening process?

The most frequently prescribed weight loss medication was semaglutide (Ozempic), followed by liraglutide (Saxenda), and dulaglutide (Trulicity).

At the state level, medication treatment rates ranged from 17.7% in Kansas to 82.8% in Maine.

A new report recommended that ketamine therapy be used only in combination with psychotherapy under the supervision of a clinician.